Trade Summary
5 days ago, Tatsis Ourania, serving as EVP, Chief Reg., Quality Offic at Vertex Pharmaceuticals Inc / Ma (VRTX), sold 977 shares at $483.52 per share, for a total transaction value of $472,395.00. Following this transaction, Tatsis Ourania now holds 48,650 shares of VRTX.
This sale represents a 2.00% decrease in Tatsis Ourania's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Tuesday, February 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 19, 2026, 2 days after the trade was made.
Vertex Pharmaceuticals Inc / Ma operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.